Swiss Primary Sclerosing Cholangitis Cohort

Swiss Primary Sclerosing Cholangitis Cohort Study

Observational Fondazione Epatocentro Ticino · NCT03146936

This project will collect blood and other biological samples plus health information from people with primary sclerosing cholangitis in Switzerland to try to better understand the disease course and treatment responses.

Quick facts

Study typeObservational
Enrollment120 (estimated)
SexAll
SponsorFondazione Epatocentro Ticino Academic / other
Locations21 sites (Lugano, Canton Ticino and 20 other locations)
Trial IDNCT03146936 on ClinicalTrials.gov

What this trial studies

This is a prospective observational cohort that will enroll people with primary sclerosing cholangitis (PSC) across Swiss referral centers and collect standardized clinical data and biological samples for a biobank. Coded health-related personal data and biospecimens will be stored to enable longitudinal tracking of disease progression, treatment responses, and outcomes. The cohort provides a platform for multiple nested research projects and for collaboration with international PSC reference networks. No investigational treatments are given as part of this protocol; participation involves data collection and sample donation.

Who should consider this trial

Good fit: People of any age diagnosed with PSC (by EASL criteria or by a hepatology referral center) who live in Switzerland are eligible to join.

Not a fit: Individuals without PSC, those living outside Switzerland, or patients seeking direct access to experimental therapies are unlikely to receive direct clinical benefit from participating.

Why it matters

Potential benefit: If successful, the cohort and biobank could lead to clearer knowledge of PSC natural history, biomarkers of progression, and improved, more personalized care strategies for patients.

How similar studies have performed: Existing national and international PSC cohorts and biobanks have produced useful epidemiologic and biomarker findings, so this cohort follows an established and productive research model.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed with PSC according to established criteria (European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases) of any age. Patients not fulfilling such criteria but still diagnosed with PSC in a hepatology referral centre can be included
* patients living in Switzerland

Exclusion Criteria:

* N/A

Where this trial is running

Lugano, Canton Ticino and 20 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Cholangitis, SclerosingPSCPrimary Sclerosing CholangitisCohort
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.